{
  "trial_id": "NCT04465162",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, stage of lymphoma (Stage 1 or Stage 2), Helicobacter pylori status, prior treatments (e.g., antibiotics, chemotherapy), site of primary disease, blood cell counts, presence of concurrent malignancy, previous radiation therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Clinical Stage",
          "stage of lymphoma (Stage 1 or Stage 2)"
        ],
        [
          "Helicobacter pylori positive at initial diagnosis",
          "Helicobacter pylori status"
        ],
        [
          "Treatment before radiation therapy",
          "prior treatments (e.g., antibiotics, chemotherapy)"
        ],
        [
          "Tumor Location",
          "site of primary disease"
        ],
        [
          "Radiation dose",
          "previous radiation therapy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Gy"
      ],
      "remaining_candidate_features": [
        "blood cell counts",
        "presence of concurrent malignancy"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Stage of MALT Lymphoma, Helicobacter pylori status, Previous treatments, Blood cell counts,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Clinical Stage",
          "Stage of MALT Lymphoma"
        ],
        [
          "Helicobacter pylori positive at initial diagnosis",
          "Helicobacter pylori status"
        ],
        [
          "Treatment before radiation therapy",
          "Previous treatments"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Tumor Location",
        "Radiation dose",
        "Gy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Blood cell counts"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Ann Arbor Stage, Extranodal Marginal Zone Lymphoma Site, H. pylori Status, Prior Treatment, Performance Status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Clinical Stage",
          "Ann Arbor Stage"
        ],
        [
          "Tumor Location",
          "Extranodal Marginal Zone Lymphoma Site"
        ],
        [
          "Helicobacter pylori positive at initial diagnosis",
          "H. pylori Status"
        ],
        [
          "Treatment before radiation therapy",
          "Prior Treatment"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Radiation dose",
        "Gy"
      ],
      "remaining_candidate_features": [
        "Performance Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, performance status, Ann Arbor stage, MALT lymphoma subtype, H. pylori status, prior antibiotic therapy, prior treatment modalities, number of extranodal sites involved, presence of B symptoms, lactate dehydrogenase (LDH) level, beta-2 microglobulin level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Clinical Stage",
          "Ann Arbor stage"
        ],
        [
          "Helicobacter pylori positive at initial diagnosis",
          "H. pylori status"
        ],
        [
          "Treatment before radiation therapy",
          "prior antibiotic therapy"
        ],
        [
          "Radiation dose",
          "prior treatment modalities"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "Tumor Location",
        "Gy"
      ],
      "remaining_candidate_features": [
        "performance status",
        "MALT lymphoma subtype",
        "number of extranodal sites involved",
        "presence of B symptoms",
        "lactate dehydrogenase (LDH) level",
        "beta-2 microglobulin level"
      ]
    }
  }
}